Inhaled nitric oxide in term infants with hypoxemic respiratory failure.

[1]  M. Keszler,et al.  Treatment of persistent pulmonary hypertension of the newborn without hyperventilation: an assessment of diffusion of innovation. , 1994, Pediatrics.

[2]  B. Yoder,et al.  Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. , 1994, The Journal of pediatrics.

[3]  N. Finer,et al.  Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. , 1994, The Journal of pediatrics.

[4]  R. Rossaint,et al.  Time‐course and dose‐response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome , 1993, European journal of clinical investigation.

[5]  M. Walsh-sukys,et al.  Persistent Pulmonary Hypertension of the Newborn: The Black Box Revisited , 1993 .

[6]  R. Rossaint,et al.  Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.

[7]  E. Shaffer,et al.  Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[8]  Jesse D. Roberts,et al.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.

[9]  M. Heymann,et al.  Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension. , 1988, The Journal of pediatrics.

[10]  R. Wennberg,et al.  Neonatal hypoxia and pulmonary vasospasm: response to tolazoline. , 1976, The Journal of pediatrics.

[11]  T. Chalmers.  Randomization of the first patient. , 1975, The Medical clinics of North America.